Tagged with MEA

Saudi Arabia Rubens Hannun, president of the Arab Brazilian Chamber of Commerce, discusses the commercial relationship between Brazil and Saudi Arabia, which now reaches over US USD three billion between imports and exports, the role of pharmaceuticals, the opportunities in halal products and their efforts to inform the Arab and Brazilian business…

Saudi Arabia In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA) outlined the organisation’s strategic priorities. As part of the Authority’s 2018-2022 strategic plan, it has set out a number of goals, ranging from setting clearer objectives to strengthening its capabilities,…

Saudi Arabia Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), outlines the SFDA’s key priorities under its current strategic plan. He also touches on why domestic pharma and medtech manufacturing is important to the SFDA, pricing issues for innovative new therapies, and…

Saudi Arabia A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision 2030’, the country’s leading position in the MENA region, why halal pharmaceuticals are not to be ignored, the regional firms playing among global giants in the Kingdom, and leading therapeutic…

MEA The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for reform of the import process for pharma products in the Arab world; Hikma’s buyup of GSK assets in Egypt and Tunisia; and Tabuk’s biosimilar distribution deal.   Pfizer…

Switzerland Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand via CMOs, and its evolution from food supplements, cosmetics and medical devices into the more strictly regulated world of pharmaceuticals.   Middle Eastern customers hold Switzerland and its pharmaceutical industry in high esteem. Manufacturing products…

MEA The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from Iran’s ban on any imports of US- or UK-produced vaccines, Israel’s world-leading vaccination speed; and how Dubai Airports is working with GMR-Hyderabad to form a ‘vaccine corridor’.   Iran inks deal for Cuban…

Saudi Arabia Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom highlights some of the top domestic companies in the USD 8.2 billion Saudi pharma market, many of which are now well-established and carving out international footprints.   Tabuk Pharmaceuticals Founded in…

Roundup A roundup of the latest from the Middle East & Africa region, including Turkey’s debt to US pharma; deals between Saudi SPIMACO and Janssen, Abu Dhabi Mubadala and Germany’s Evotec, and Turkey’s Abdi Ibrahim and Swiss OM Pharma; and whether poorer countries in Africa can truly expect equal access to…

Vaccines While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West Africa, the highly infectious and lethal disease has generated global trepidation due to its characteristic haemorrhagic fever, a 50 percent chance of death on average, and the absence of any approved treatment. The…

Saudi Arabia The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales in the USD 8.2 billion Saudi pharma market. Global giants Pfizer, Sanofi, and Novartis make up the top three spots, but…

Roundup A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE firm Mubadala’s latest US investment, Saudi Arabia’s continuing digitalisation push, and Algeria’s plan to export USD five billion in domestically…